MY129370A - New anhydrous crystalline forms of gabapentin - Google Patents
New anhydrous crystalline forms of gabapentinInfo
- Publication number
- MY129370A MY129370A MYPI20023726A MY129370A MY 129370 A MY129370 A MY 129370A MY PI20023726 A MYPI20023726 A MY PI20023726A MY 129370 A MY129370 A MY 129370A
- Authority
- MY
- Malaysia
- Prior art keywords
- gabapentin
- crystalline forms
- anhydrous crystalline
- new anhydrous
- new
- Prior art date
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title abstract 4
- 229960002870 gabapentin Drugs 0.000 title abstract 2
- WRSFRDZQQUAKNA-UHFFFAOYSA-N 2-[1-(aminomethyl)cyclohexyl]acetic acid;hydrate Chemical compound O.OC(=O)CC1(CN)CCCCC1 WRSFRDZQQUAKNA-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32837501P | 2001-10-09 | 2001-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY129370A true MY129370A (en) | 2007-03-30 |
Family
ID=34589923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20023726 MY129370A (en) | 2001-10-09 | 2002-10-04 | New anhydrous crystalline forms of gabapentin |
Country Status (13)
| Country | Link |
|---|---|
| AR (1) | AR036695A1 (es) |
| DO (1) | DOP2002000474A (es) |
| GT (1) | GT200200204A (es) |
| HN (1) | HN2002000283A (es) |
| MY (1) | MY129370A (es) |
| PA (1) | PA8555901A1 (es) |
| PE (1) | PE20030689A1 (es) |
| PY (1) | PY0224072A (es) |
| SV (1) | SV2004001275A (es) |
| TW (1) | TWI245033B (es) |
| UA (1) | UA77021C2 (es) |
| UY (1) | UY27473A1 (es) |
| ZA (1) | ZA200402519B (es) |
-
2002
- 2002-03-10 UA UA20040503407A patent/UA77021C2/uk unknown
- 2002-09-25 TW TW91122057A patent/TWI245033B/zh not_active IP Right Cessation
- 2002-09-27 AR ARP020103664 patent/AR036695A1/es unknown
- 2002-10-01 DO DO2002000474A patent/DOP2002000474A/es unknown
- 2002-10-01 PY PY200200224072A patent/PY0224072A/es unknown
- 2002-10-04 HN HN2002000283A patent/HN2002000283A/es unknown
- 2002-10-04 MY MYPI20023726 patent/MY129370A/en unknown
- 2002-10-04 PE PE2002000988A patent/PE20030689A1/es not_active Application Discontinuation
- 2002-10-07 UY UY27473A patent/UY27473A1/es not_active Application Discontinuation
- 2002-10-08 SV SV2002001275A patent/SV2004001275A/es not_active Application Discontinuation
- 2002-10-09 PA PA8555901A patent/PA8555901A1/es unknown
- 2002-10-09 GT GT200200204A patent/GT200200204A/es unknown
-
2004
- 2004-03-30 ZA ZA200402519A patent/ZA200402519B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GT200200204A (es) | 2003-05-23 |
| AR036695A1 (es) | 2004-09-29 |
| PA8555901A1 (es) | 2003-06-30 |
| DOP2002000474A (es) | 2003-04-15 |
| SV2004001275A (es) | 2004-02-24 |
| HN2002000283A (es) | 2005-02-22 |
| UA77021C2 (en) | 2006-10-16 |
| PE20030689A1 (es) | 2003-08-11 |
| UY27473A1 (es) | 2003-05-30 |
| ZA200402519B (en) | 2005-01-24 |
| TWI245033B (en) | 2005-12-11 |
| PY0224072A (es) | 2004-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20105036B (en) | Perindopril | |
| IL163725A0 (en) | Administration of agents for the treatment of inflammation | |
| GEP20074098B (en) | Lactam-containing compounds and derivatives thereof as factor xa inhibitors | |
| BG108269A (en) | Pyrazolopyrimidines as therapeutic agents | |
| IS6069A (is) | N-cýanómetýlamíð sem próteasalatar | |
| MXPA03010766A (es) | Nuevos compuestos y composiciones como inhibicores de las catepsinas. | |
| AP2004003025A0 (en) | New anhydrous crystalline forms of gabapentin | |
| IL163871A0 (en) | Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders | |
| TR200103125T2 (tr) | Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri. | |
| LT1496918T (lt) | Natrio meta-arsenito naudojimas navikams gydyti | |
| PL397022A1 (pl) | Środek leczniczy | |
| MY136288A (en) | New process for the synthesis of perindopril and its pharmaceutically acceptable salts | |
| ITTO20020997A1 (it) | Procedimento autoalllineato per la fabbricazione di | |
| GB0003048D0 (en) | The therapeutic use of polysulphonated polyglycosides or other polyanionic compounds in autism | |
| AU2003208368A1 (en) | Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases | |
| ZA200402519B (en) | New anhydrous crystalline forms of gabapentin. | |
| MXPA03000856A (es) | Agente terapeutico cristalino. | |
| HK40032312A (en) | Administration of agents for the treatment of inflammation | |
| AU2003244633A1 (en) | Methods for the treatment of sinusitis | |
| UA67433A (en) | Treatment-and-prophylaxis urolit composition | |
| AU2003227519A1 (en) | The use of milnacipran for the treatment of tension-type headache | |
| AU2003222141A8 (en) | Ctla4 compositions in the treatment of autism | |
| AP2002002566A0 (en) | Monohydrate of cis-lithium-cynao-4-Ä3-(cyclopentloxy)-4-methoxyphenylÜ cyclohexanecarboxylate | |
| WO2002055064A3 (en) | Mucopolysaccharidosis therapies | |
| ECSP045042A (es) | Nuevas formas cristalinas anhidras de la gabapentina |